Simplex Trading
XERS icon

Simplex Trading’s Xeris Biopharma Holdings XERS Stock Holding History

Simplex Trading’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
+19,900
New +$132K ﹤0.01% 4919
2025
Q4 		– Sell
-92,600
Closed -$753K – 10291
2025
Q3 		$753K Buy
92,600
+56,400
+156% +$375K ﹤0.01% 3343
2025
Q2 		$169K Sell
36,200
-21,800
-38% -$99.9K ﹤0.01% 4689
2025
Q1 		$318K Sell
58,000
-5,600
-9% -$22.6K ﹤0.01% 3878
2024
Q4 		$215K Sell
63,600
-13,400
-17% -$43.1K ﹤0.01% 4437
2024
Q3 		$219K Buy
77,000
+5,400
+8% +$13.9K ﹤0.01% 4433
2024
Q2 		$161K Sell
71,600
-21,300
-23% -$42.9K ﹤0.01% 4861
2024
Q1 		$205K Sell
92,900
-43,700
-32% -$113K ﹤0.01% 4828
2023
Q4 		$321K Sell
136,600
-10,200
-7% -$18.8K ﹤0.01% 4151
2023
Q3 		$273K Buy
146,800
+1,500
+1% +$3.44K ﹤0.01% 4031
2023
Q2 		$380K Buy
145,300
+53,300
+58% +$136K ﹤0.01% 3590
2023
Q1 		$149K Sell
92,000
-103,500
-53% -$130K ﹤0.01% 4682
2022
Q4 		$260K Buy
195,500
+24,800
+15% +$35K ﹤0.01% 3904
2022
Q3 		$266K Sell
170,700
-30,700
-15% -$50.8K ﹤0.01% 4240
2022
Q2 		$310K Buy
201,400
+78,600
+64% +$166K ﹤0.01% 4062
2022
Q1 		$314K Buy
122,800
+25,300
+26% +$61.8K ﹤0.01% 4489
2021
Q4 		$285K Sell
97,500
-55,500
-36% -$120K ﹤0.01% 4650
2021
Q3 		$638K Buy
153,000
+7,900
+5% +$22.9K ﹤0.01% 3727
2021
Q2 		$590K Buy
145,100
+144,068
+13,960% +$550K ﹤0.01% 3896
2021
Q1 		$465K Sell
1,032
-370
-26% -$2K ﹤0.01% 3481
2020
Q4 		$689K Buy
1,402
+1,198
+587% +$5.99K ﹤0.01% 3036
2020
Q3 		$120K Buy
+204
New +$816 ﹤0.01% 4704
2020
Q1 		– Sell
-2
Closed -$1K – 8382
2019
Q4 		$1K Buy
+2
New +$17 ﹤0.01% 7139

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's XERS Position: Q4 2025 in Review

Simplex Trading sold out of Xeris Biopharma Holdings (XERS) in Q4 2025, closing a stake of 45,931 shares — an estimated $373K sold.

Simplex Trading first reported a position in XERS in Q2 2020 and held it in 9 quarters. The position peaked at $941K in Q4 2021. 225 funds tracked by Wall St. Rank hold XERS as of Q4 2025.

  • Simplex Trading reported no remaining Xeris Biopharma Holdings position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 45,931 Xeris Biopharma Holdings shares in Q4 2025, an estimated $373K.
  • Simplex Trading first reported a position in Xeris Biopharma Holdings in Q2 2020 and held it in 9 quarters.
  • Simplex Trading's Xeris Biopharma Holdings position peaked at $941K in Q4 2021.
  • 225 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.